← The Coverage Log

COVERAGE LOG

ZIVO 4

Zivo Bioscience, Inc. · SEC filing date January 28, 2026

Filing date
January 28, 2026
Ticker
ZIVO
Company
Zivo Bioscience, Inc.
Form
4
Flags
Ceo purchaseExecutive purchaseInsider buyLarge purchaseOwnership increase
Filing
Open on EDGAR

Summary

PAYNE JOHN BERNARD (Director, President and CEO) bought 11709 shares of Zivo Bioscience, Inc. (CIK: 0001101026) at $8.54/share. This is a bullish signal because it indicates confidence from the CEO/President.

This page is one entry in NexusAlert's public Coverage Log. The date is the SEC filing date — the date the filing was filed with the SEC. The summary is what NexusAlert wrote when it read the filing, shown unedited. Rows are never silently rewritten after they appear in the log. See the full log →

Financial Disclaimer

No Investment Advice: The analysis, data, and information provided by Nexus Alert are generated by Artificial Intelligence (AI) for general informational and educational purposes only. This content does not constitute financial, investment, legal, or tax advice. It is not an offer or solicitation to buy or sell any security or financial instrument.

Accuracy and Risks: While we strive for accuracy, AI-generated content may contain errors, omissions, or inaccuracies. Financial markets are inherently volatile and past performance is not indicative of future results. The algorithms used do not account for your personal financial goals, risk tolerance, or time horizon.

Consult a Professional: You should not make any investment decisions based solely on this information. We strongly recommend that you conduct your own independent research and consult with a qualified, licensed financial advisor or professional before making any financial commitments.

Limitation of Liability: Nexus Alert and its affiliates shall not be held liable for any financial losses or damages resulting from the use of or reliance on the information provided by the Service.

Want these as they happen? Search every filing free, or start a Pro trial.

Start free Pro trial →